Stay updated on VERTIS CV Study in T2DM: Cardiovascular Outcomes Clinical Trial

Sign up to get notified when there's something new on the VERTIS CV Study in T2DM: Cardiovascular Outcomes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VERTIS CV Study in T2DM: Cardiovascular Outcomes Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    No significant differences between the screenshots; the study record details, eligibility criteria, outcomes, and contacts appear unchanged.
    Difference
    0.3%
    Check dated 2025-10-28T05:16:42.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    - Added MedlinePlus Genetics topic on Type 2 diabetes; no deletions.
    Difference
    0.1%
    Check dated 2025-10-21T01:32:45.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed MedlinePlus Genetics topic: Type 2 diabetes. This narrows the genetics topics covered without adding new content.
    Difference
    0.1%
    Check dated 2025-10-13T21:00:05.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    - The page shows a version update from v3.1.0 to v3.2.0, indicating a new revision release. - A prominent operational notice has been added about potential delays in updates and processing due to funding lapse; it also directs users to cc.nih.gov and opm.gov for status details, which is an important core content and time-sensitive information. - A new topic area is added under MedlinePlus Genetics: Type 2 diabetes. - No other substantive deletions beyond the removal of the old revision note (v3.1.0) are present. If you consider the denomination of the previous revision as less relevant, the primary meaningful change is the new revision, the new operational notice, and the new topic area.
    Difference
    0.8%
    Check dated 2025-10-06T16:03:52.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Version bump to v3.1.0 with removal of several health/drug-safety topics (e.g., Type 2 diabetes, Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and no new substantive content added.
    Difference
    0.1%
    Check dated 2025-09-29T10:00:07.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Added coverage: MedlinePlus Genetics topic on Type 2 diabetes, expanding the page’s scope without removing existing content.
    Difference
    0.1%
    Check dated 2025-09-22T05:39:44.000Z thumbnail image

Stay in the know with updates to VERTIS CV Study in T2DM: Cardiovascular Outcomes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VERTIS CV Study in T2DM: Cardiovascular Outcomes Clinical Trial page.